Your browser doesn't support javascript.
loading
Pfizer-BioNTech Coronavirus Disease 2019 Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Long-term Care Facility Staff With and Without Prior Infection in New York City, January-June 2021.
Peebles, Kathryn; Arciuolo, Robert J; Romano, Anthony S; Sell, Jessica; Greene, Sharon K; Lim, Sungwoo; Mulready-Ward, Candace; Ternier, Alexandra; Badenhop, Brittan; Blaney, Kathleen; Real, Joseph E; Spencer, Magdalene; McPherson, Tristan D; Ahuja, Shama Desai; Sullivan Meissner, Jeanne; Zucker, Jane R; Rosen, Jennifer B.
Afiliación
  • Peebles K; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Arciuolo RJ; Division of Epidemiology, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Romano AS; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Sell J; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Greene SK; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Lim S; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Mulready-Ward C; Division of Epidemiology, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Ternier A; Division of Family and Child Health, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Badenhop B; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Blaney K; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Real JE; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Spencer M; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • McPherson TD; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Ahuja SD; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Sullivan Meissner J; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Zucker JR; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
  • Rosen JB; Division of Disease Control, New York City Department of Health and Mental Hygiene, Queens, New York, USA.
J Infect Dis ; 227(4): 533-542, 2023 02 14.
Article en En | MEDLINE | ID: mdl-36626187
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas contra la COVID-19 / COVID-19 Tipo de estudio: Guideline / Prognostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: J Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos